Choksi Laborator

{
  "main_header": {
    "sid": 525405,
    "name": "Choksi Laborator",
    "stock_name": "Choksi Laborator",
    "full_name": "Choksi Laboratories Ltd",
    "name_url": "stocks-analysis/choksi-laborator",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "125.90",
    "chg": 9.65,
    "chgp": "8.3%",
    "dir": 1,
    "prev_price": "116.25",
    "mcapval": "90.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526546,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE493D01013",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": "443 ",
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/choksi-laborator-525405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Choksi Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-choksi-laboratories-ltd-latest-results-good-or-bad-3826810",
        "imagepath": "",
        "date": "2026-02-07 19:17:55",
        "description": "Choksi Laboratories Ltd reported its financial results for the quarter ending December 2025, reflecting a mixed operational performance. The company achieved a net profit of ₹0.31 crores, which represents a significant year-on-year growth of 181.82%. This growth is notable, especially when compared to the previous year's performance. However, the revenue for the same period amounted to ₹10.82 crores, indicating a modest year-on-year increase of 4.24%, which is a decline from the previous year's growth rate of 18.09%.\n\nThe operating margin for Choksi Laboratories stood at 24.31%, showing a compression of 204 basis points from the previous quarter, which raises concerns about operational efficiency. Additionally, the company faced an unusually high tax rate of 65.56%, which has impacted the net profit margin, leaving it at a mere 2.87%. This high tax rate may suggest potential issues with earnings quality or ..."
      },
      {
        "title": "Choksi Laboratories Q3 FY26: Profit Surge Masked by Margin Compression and Tax Anomalies",
        "link": "https://www.marketsmojo.com/news/result-analysis/choksi-laboratories-q3-fy26-profit-surge-masked-by-margin-compression-and-tax-anomalies-3826782",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ChoksiLaborator_quaterlyResult_3826782.png",
        "date": "2026-02-07 17:46:55",
        "description": "Choksi Laboratories Ltd., a micro-cap contract testing and analytical services provider with a market capitalisation of ₹85.00 crores, reported a net profit of ₹0.31 crores for Q3 FY26 (October-December 2025), representing a sequential increase of 29.17% quarter-on-quarter but a substantial 181.82% surge year-on-year from ₹0.11 crores in Q3 FY25. However, the headline profit growth conceals troubling underlying trends, including persistent margin compression, an extraordinarily high tax rate of 65.56%, and declining operating efficiency that raise serious questions about the sustainability of this performance."
      },
      {
        "title": "When is the next results date for Choksi Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-choksi-laboratories-ltd-3819092",
        "imagepath": "",
        "date": "2026-02-03 23:16:30",
        "description": "The next results date for Choksi Laboratories Ltd is scheduled for February 7, 2026...."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-sell-3811182",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ChoksiLaborator_mojoScore_3811182.png",
        "date": "2026-01-30 10:10:03",
        "description": "Choksi Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-sell-3794132",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ChoksiLaborator_mojoScore_3794132.png",
        "date": "2026-01-19 10:10:03",
        "description": "Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-sell-3783204",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ChoksiLaborator_mojoScore_3783204.png",
        "date": "2026-01-06 10:10:10",
        "description": "Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-sell-3769915",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ChoksiLaborator_mojoScore_3769915.png",
        "date": "2025-12-25 15:12:04",
        "description": "Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Why is Choksi Laborator falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-choksi-laborator-fallingrising-3749380",
        "imagepath": "",
        "date": "2025-12-06 00:41:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Choksi Laboratories has been experiencing a consecutive seven-day decline, resulting in a cumulative loss of approximately 15.88% over this period. This contrasts sharply with the broader market benchmark, the Sensex, which has remained relatively flat with a marginal gain of 0.01% over the same week. The stock’s underperformance today was also evident as it lagged its sector by 2.5%, signalling sector-relative weakness.</p>\n<p>Intraday price action on 05-Dec showed volatility, with the stock reaching a high of ₹124.50, up 2.01% from the previous close, before retreating to an intraday low of ₹118, down 3.32%. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, suggesting selling dominan..."
      },
      {
        "title": "Choksi Laboratories Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/choksi-laboratories-forms-death-cross-signalling-potential-bearish-trend-3747042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ChoksiLaborator_dealthcross_3747042.png",
        "date": "2025-12-04 18:01:35",
        "description": "Choksi Laboratories, a player in the Healthcare Services sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price trajectory."
      }
    ],
    "total": 281,
    "sid": "525405",
    "stock_news_url": "https://www.marketsmojo.com/news/choksi-laboratories-525405"
  },
  "announcements": [
    {
      "caption": "Financial Result For The Quarter And Nine Month Ended 31.12.2025",
      "datetime": "07-Feb-2026",
      "details": "Considered and approved quarterly financial result for the period ended 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Re-Constitution Of Various Committees Of Board Of Directors Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015",
      "datetime": "07-Feb-2026",
      "details": "Intimation of Reconstitution of committees of board of directors",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome For Meeting Of Board Of Directors Held On 07Th February 2026",
      "datetime": "07-Feb-2026",
      "details": "1. Considered and approved Unaudited Financial Results for the Quarter and Nine Month ended 31st December 2025 along with the Limited review report; 2. Appointment of Mr. Ritik Pavecha (DIN: 08790431) as an Additional Director of the Company in the category of the Non-Executive Independent Director w.e.f. 07th February 2026 subject to the Conformation of the Members 3. Taken on record the cessation of directorship of Mrs. Meenaxi Patidar (DIN: 10206356) due to resignation from the position of Non-Executive Independent Director of the company; 4. Approved postal ballot notice for seeking consent of Members of the Company for the resolutions as set out in the postal ballot Notice and other matters incidental thereto; 5. Approved the appointment of M/s. Surabhi Agrawal Practicing Company Secretary (COP No. 23696) as Scrutinizer to scrutinize the postal ballot process in a fair and transparent manner. 6. Other routine businesses with the permission of chair.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Choksi Laboratories Ltd latest results good or bad?

2026-02-07 19:17:55

Choksi Laboratories Ltd reported its financial results for the quarter ending December 2025, reflecting a mixed operational performance. The company achieved a net profit of ₹0.31 crores, which represents a significant year-on-year growth of 181.82%. This growth is notable, especially when compared to the previous year's performance. However, the revenue for the same period amounted to ₹10.82 crores, indicating a modest year-on-year increase of 4.24%, which is a decline from the previous year's growth rate of 18.09%. The operating margin for Choksi Laboratories stood at 24.31%, showing a compression of 204 basis points from the previous quarter, which raises concerns about operational efficiency. Additionally, the company faced an unusually high tax rate of 65.56%, which has impacted the net profit margin, leaving it at a mere 2.87%. This high tax rate may suggest potential issues with earnings quality or ...

Read full news article

Choksi Laboratories Q3 FY26: Profit Surge Masked by Margin Compression and Tax Anomalies

2026-02-07 17:46:55

Choksi Laboratories Ltd., a micro-cap contract testing and analytical services provider with a market capitalisation of ₹85.00 crores, reported a net profit of ₹0.31 crores for Q3 FY26 (October-December 2025), representing a sequential increase of 29.17% quarter-on-quarter but a substantial 181.82% surge year-on-year from ₹0.11 crores in Q3 FY25. However, the headline profit growth conceals troubling underlying trends, including persistent margin compression, an extraordinarily high tax rate of 65.56%, and declining operating efficiency that raise serious questions about the sustainability of this performance.

Read full news article

When is the next results date for Choksi Laboratories Ltd?

2026-02-03 23:16:30

The next results date for Choksi Laboratories Ltd is scheduled for February 7, 2026....

Read full news article

Choksi Laboratories Ltd is Rated Sell

2026-01-30 10:10:03

Choksi Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Choksi Laboratories Ltd is Rated Sell

2026-01-19 10:10:03

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Choksi Laboratories Ltd is Rated Sell

2026-01-06 10:10:10

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Choksi Laboratories Ltd is Rated Sell

2025-12-25 15:12:04

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Choksi Laborator falling/rising?

2025-12-06 00:41:10

Recent Price Movement and Market Context

Choksi Laboratories has been experiencing a consecutive seven-day decline, resulting in a cumulative loss of approximately 15.88% over this period. This contrasts sharply with the broader market benchmark, the Sensex, which has remained relatively flat with a marginal gain of 0.01% over the same week. The stock’s underperformance today was also evident as it lagged its sector by 2.5%, signalling sector-relative weakness.

Intraday price action on 05-Dec showed volatility, with the stock reaching a high of ₹124.50, up 2.01% from the previous close, before retreating to an intraday low of ₹118, down 3.32%. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, suggesting selling dominan...

Read full news article

Choksi Laboratories Forms Death Cross, Signalling Potential Bearish Trend

2025-12-04 18:01:35

Choksi Laboratories, a player in the Healthcare Services sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price trajectory.

Read full news article

View All News